Life Sciences

This research service encompasses microbiome technology trends and emerging innovations across: Disease Management This research segment explores the emerging role of microbiome-based therapeutics across a wide range of diseases, especially in the context of gastro-intestinal health, while providing strategic insights across the highly dynamic com...

The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends in genetic engineering techniques across the United States. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of gene...

This edition of the Medical Device TOE depicts the current landscape and the new regional innovative trends in San Diego. Innovations in medical devices companies in San Diego are illustrated along with examples of few industry participants. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologi...

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across immunotherapy. The corresponding patent scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportun...

This edition of the Drug Discovery TOE depicts the current landscape and the new life sciences trends across the pharmaceutical industry in South Africa. South Africa has a diversified manufacturing industry that focuses on production of pharmaceutical and biotechnology products. Critical programmes were launched by the Department of Trade and Indu...

The latest edition of the Medical Diagnostics and Imaging TOE depicts the current landscape and new trends across fluoroscopic imaging devices. Novel digital imaging solutions for fluoroscopy and radiography along with industry interactions have been presented. Medical and Diagnostic Imaging TechVision Opportunity Engine (TOE)'s mission is to anal...